Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review

Overview

Journal Indian J Microbiol

Specialty Microbiology

Date 2024 Sep 16

PMID 39282181

Authors

Hattiangadi Shruthi Kamath

Rushikesh Shukla

Urmil Shah

Siddhi Patel

Soumyajit Das

Ayush Chordia

Poorvikha Satish

Dibyankita Ghosh

Affiliations

Soon will be listed here.

Abstract

Globally, colorectal cancer (CRC) is a leading cause of cancer-related mortality. Dietary habits, inflammation, hereditary characteristics, and gut microbiota are some of its causes. The gut microbiota, a diverse population of bacteria living in the digestive system, has an impact on a variety of parameters, including inflammation, DNA damage, and immune response. The gut microbiome has a significant role in colon cancer susceptibility. Many studies have highlighted dysbiosis, an imbalance in the gut microbiota's makeup, as a major factor in colon cancer susceptibility. Dysbiosis has the potential to produce toxic metabolites and pro-inflammatory substances, which can hasten the growth of tumours. The ability of the gut microbiota to affect the host's immune system can also influence whether cancer develops or not. By better comprehending these complex interactions between colon cancer predisposition and gut flora, new preventive and therapeutic techniques might be developed. Targeting the gut microbiome with dietary modifications, probiotics, or faecal microbiota transplantation may offer cutting-edge approaches to reducing the risk of colon cancer and improving patient outcomes. The complex connection between the makeup of the gut microbiota and the emergence of colorectal cancer is explored in this narrative review.

References

Burtin F, Mullins C, Linnebacher M . Mouse models of colorectal cancer: Past, present and future perspectives. World J Gastroenterol. 2020; 26(13):1394-1426. PMC: 7152519. DOI: 10.3748/wjg.v26.i13.1394. View

Klein R, Catalano M, Edberg S, CASEY J, STEIGBIGEL N . Streptococcus bovis septicemia and carcinoma of the colon. Ann Intern Med. 1979; 91(4):560-2. DOI: 10.7326/0003-4819-91-4-560. View

Zackular J, Baxter N, Iverson K, Sadler W, Petrosino J, Chen G . The gut microbiome modulates colon tumorigenesis. mBio. 2013; 4(6):e00692-13. PMC: 3892781. DOI: 10.1128/mBio.00692-13. View

Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z . Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015; 6:6528. DOI: 10.1038/ncomms7528. View

Boyer L, Travaglione S, Falzano L, Gauthier N, Popoff M, Lemichez E . Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell. 2003; 15(3):1124-33. PMC: 363090. DOI: 10.1091/mbc.e03-05-0301. View

Xu J, Yang M, Wang D, Zhang S, Yan S, Zhu Y . Alteration of the abundance of in the gut along the adenoma-carcinoma sequence. Oncol Lett. 2020; 20(4):106. PMC: 7439112. DOI: 10.3892/ol.2020.11967. View

Lin Y, Lau H, Liu Y, Kang X, Wang Y, Ting N . Altered Mycobiota Signatures and Enriched Pathogenic Aspergillus rambellii Are Associated With Colorectal Cancer Based on Multicohort Fecal Metagenomic Analyses. Gastroenterology. 2022; 163(4):908-921. DOI: 10.1053/j.gastro.2022.06.038. View

Chuang L, Chen H, You S, Lin C, Pan M, Chou Y . Association between human papillomavirus and adenocarcinoma of rectum and recto-sigmoid junction: a cohort study of 10,612 women in Taiwan. Cancer Causes Control. 2010; 21(12):2123-8. DOI: 10.1007/s10552-010-9631-5. View

Bhome R, Goh R, Bullock M, Pillar N, Thirdborough S, Mellone M . Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. Aging (Albany NY). 2017; 9(12):2666-2694. PMC: 5764398. DOI: 10.18632/aging.101355. View

10.

Collins D, Hogan A, Winter D . Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2010; 12(5):504-12. DOI: 10.1016/S1470-2045(10)70186-8. View

11.

Francia G, Cruz-Munoz W, Man S, Xu P, Kerbel R . Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer. 2011; 11(2):135-41. PMC: 4540342. DOI: 10.1038/nrc3001. View

12.

Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R . Exploring the Role of Gut Microbiome in Colon Cancer. Appl Biochem Biotechnol. 2021; 193(6):1780-1799. DOI: 10.1007/s12010-021-03498-9. View

13.

Cuevas-Ramos G, Petit C, Marcq I, Boury M, Oswald E, Nougayrede J . Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 2010; 107(25):11537-42. PMC: 2895108. DOI: 10.1073/pnas.1001261107. View

14.

Burnett-Hartman A, Newcomb P, Potter J . Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev. 2008; 17(11):2970-9. PMC: 2676114. DOI: 10.1158/1055-9965.EPI-08-0571. View

15.

Katsiampoura A, Raghav K, Jiang Z, Menter D, Varkaris A, Morelli M . Modeling of Patient-Derived Xenografts in Colorectal Cancer. Mol Cancer Ther. 2017; 16(7):1435-1442. PMC: 5562363. DOI: 10.1158/1535-7163.MCT-16-0721. View

16.

Yang Y, Weng W, Peng J, Hong L, Yang L, Toiyama Y . Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. Gastroenterology. 2016; 152(4):851-866.e24. PMC: 5555435. DOI: 10.1053/j.gastro.2016.11.018. View

17.

Koulos J, Symmans F, Chumas J, Nuovo G . Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol. 1991; 4(1):58-61. View

18.

Dai Z, Coker O, Nakatsu G, Wu W, Zhao L, Chen Z . Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome. 2018; 6(1):70. PMC: 5896039. DOI: 10.1186/s40168-018-0451-2. View

19.

Davenport J, Cai Q, Ness R, Milne G, Zhao Z, Smalley W . Evaluation of pro-inflammatory markers plasma C-reactive protein and urinary prostaglandin-E2 metabolite in colorectal adenoma risk. Mol Carcinog. 2015; 55(8):1251-61. PMC: 4816675. DOI: 10.1002/mc.22367. View

20.

Nguyen T, Vieira-Silva S, Liston A, Raes J . How informative is the mouse for human gut microbiota research?. Dis Model Mech. 2015; 8(1):1-16. PMC: 4283646. DOI: 10.1242/dmm.017400. View